Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -952 | -9,892 | -6,885 | -5,851 | -4,211 |
| Depreciation Amortization | 465 | 2,754 | N/A | -15 | 2,508 |
| Accounts receivable | N/A | 2 | 2 | -32 | 2 |
| Accounts payable and accrued liabilities | 159 | 470 | 584 | 189 | -87 |
| Other Working Capital | 251 | 1,630 | 936 | 284 | -343 |
| Other Operating Activity | -135 | 1,749 | 3,188 | 3,519 | 700 |
| Operating Cash Flow | $-211 | $-3,287 | $-2,173 | $-1,907 | $-1,430 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 182 | 738 | 488 | N/A | 488 |
| Debt Issued | N/A | N/A | 250 | 488 | N/A |
| Debt Repayment | -34 | -138 | -104 | -264 | -34 |
| Common Stock Issued | N/A | 1,700 | 395 | 150 | N/A |
| Other Financing Activity | 0 | -488 | -342 | 0 | -49 |
| Financing Cash Flow | $148 | $1,812 | $688 | $374 | $405 |
| Beginning Cash Position | 67 | 1,542 | 1,542 | 1,542 | 1,542 |
| End Cash Position | 4 | 67 | 57 | 10 | 517 |
| Net Cash Flow | $-63 | $-1,474 | $-1,485 | $-1,533 | $-1,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -211 | -3,287 | -2,173 | -1,907 | -1,430 |
| Free Cash Flow | -211 | -3,287 | -2,173 | -1,907 | -1,430 |